Abstract
We previously demonstrated that the inhibition of soluble epoxide hydrolase, which metabolizes vasodilator and anti-inflammatory eicosanoids, displays protective effects against left ventricular dysfunction in a rat model of ischemic heart failure. However, its remains to be investigated the impact of sEH inhibition on pulmonary vascular and right heart dysfunctions that are known to aggravate the prognostic of left heart diseases. To study the impact of sEH inhibition on pulmonary vascular and right heart dysfunctions in left heart diseases. Ischemic heart failure was induced by definitive coronary artery ligation in Sprague–Dawley rats. Pulmonary vascular function (Mulvany), oedema (lung wet weight - dry weight), right ventricular function (cardiac MRI) and remodelling (right ventricular weight and fibrosis) were assessed in sham-operated rats and rats with HF treated or not by the sEH inhibitor TPPU (5 mg/L in drinking water) during 12 weeks. Rats with heart failure displayed a marked alteration in pulmonary smooth muscle constriction to norepinephrin and in pulmonary endothelial-dependent relaxation to acetylcholine, pulmonary edema, and an increase in right ventricular weight but not in fibrosis compared to sham-operated rats. TPPU did not modify these parameters in sham-operated rats but improved pulmonary relaxation to acetylcholine in rats with heart failure and reduced pulmonary edema without affecting right ventricular weight and fibrosis. Data obtained by cardiac MRI are currently being analysed. These preliminary results demonstrate that sEH inhibition improves pulmonary endothelial function in rats with heart failure, which could contribute to the beneficial effects of this new pharmacological class in the context of left heart diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
